NVRO - Nevro Corp
Close
6.19
-0.150 -2.423%
Share volume: 925,112
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$6.34
-0.15
-2.37%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-02-21 | 2023-04-26 | 2023-08-01 | 2023-11-01 | 2024-02-23 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 523.916 M | 605.512 M | 602.408 M | 574.424 M | 569.518 M | 561.582 M | 635.713 M | 596.050 M | |
| Current Assets | 483.302 M | 566.073 M | 562.937 M | 535.457 M | 531.348 M | 521.983 M | 530.921 M | 492.604 M | |
| Inventories | 93.520 M | 98.525 M | 99.638 M | 113.293 M | 120.088 M | 122.420 M | 118.676 M | 120.789 M | |
| Other Current Assets | 12.056 M | 11.080 M | 9.984 M | 14.673 M | 11.918 M | 10.321 M | 10.145 M | 13.414 M | |
| Short Term Investments | 12.056 M | 11.080 M | 9.984 M | 14.673 M | 11.918 M | 10.321 M | 10.145 M | 13.414 M | |
| Total Receivables | 66.903 M | 69.572 M | 78.930 M | 65.725 M | 69.400 M | 68.984 M | 79.377 M | 76.918 M | |
| Current Cash | 310.823 M | 386.896 M | 374.385 M | 341.766 M | 329.942 M | 320.258 M | 322.723 M | 281.483 M | |
| Total Non-current Assets | 40.614 M | 39.439 M | 39.471 M | 38.967 M | 38.170 M | 39.599 M | 104.792 M | 103.446 M | |
| Property Plant Equipment | 20.790 M | 21.173 M | 22.271 M | 22.911 M | 23.526 M | 24.031 M | 24.568 M | 24.708 M | |
| Other Assets | 3.675 M | 3.163 M | 3.164 M | 3.109 M | 2.807 M | 4.863 M | 5.156 M | 5.427 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 27.354 M | 26.617 M | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 38.164 M | 38.324 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 523.916 M | 605.512 M | 602.408 M | 574.424 M | 569.518 M | 561.582 M | 635.713 M | 596.050 M | |
| Total liabilities | 293.931 M | 280.577 M | 278.532 M | 273.196 M | 274.768 M | 275.916 M | 342.568 M | 317.509 M | |
| Total current liabilities | 72.666 M | 80.298 M | 79.212 M | 74.919 M | 77.529 M | 79.743 M | 83.375 M | 66.774 M | |
| Accounts Payable | 31.298 M | 31.839 M | 26.849 M | 29.229 M | 30.298 M | 28.854 M | 22.520 M | 21.208 M | |
| Other liabilities | 22.079 M | 2.096 M | 2.157 M | 2.157 M | 2.199 M | 2.265 M | 43.088 M | 32.836 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 186.256 M | 186.559 M | 186.867 M | 187.175 M | 187.489 M | 187.803 M | 211.471 M | 214.763 M | |
| Other liabilities | 22.079 M | 2.096 M | 2.157 M | 2.157 M | 2.199 M | 2.265 M | 43.088 M | 32.836 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 229.985 M | 324.935 M | 323.876 M | 301.228 M | 294.750 M | 285.666 M | 293.145 M | 278.541 M | |
| Common stock | 35.318 M | 35.402 M | 35.477 M | 35.585 M | 35.922 M | 36.142 M | 36.277 M | 36.467 M | |
| Retained earnings | -669.513 M | -588.005 M | -607.197 M | -642.226 M | -666.950 M | -690.429 M | -699.410 M | -724.819 M |